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Background: Previous epidemiological studies have presented conflicting evidence regarding associations between
interleukin-1 (IL-1) polymorphisms and sepsis susceptibility. We have performed a meta-analysis to evaluate possible
associations between IL-1 polymorphisms and sepsis risk.
Methods: Eligible literature was retrieved from PubMed, Embase and Web of Knowledge databases until Jun 15,
2013. The pooled odds ratio (OR) and 95% confidence interval (CI) were calculated using random-effects model in
the overall and subgroup analysis based on ethnicity, sepsis severity and quality score.
Results: Eighteen studies addressing five IL-1 polymorphisms were included in this meta-analysis. For IL-1A-889
(rs1800587) polymorphism, significant association was observed in overall comparison for allelic effect (OR = 1.47,
95% CI = 1.01-2.13, P = 0.04). There were no significant associations between either IL-1B-511 (rs16944) or IL-1B-31
(rs1143627) and sepsis susceptibility in overall or subgroup analyses. For IL-1B + 3594 (rs143634) polymorphism,
genotype TT decreased sepsis risk in overall analysis (OR = 0.59, 95% CI = 0.36-0.97, P = 0.04), as well as in Caucasian
(OR = 0.57, 95% CI = 0.34-0.95, P = 0.03) and sepsis (OR = 0.55, 95% CI = 0.31-0.97, P = 0.04) subgroup analysis. For
IL-1RN VNTR polymorphism, significant association was observed in overall comparison for allelic effect (OR = 1.40,
95% CI = 1.01-1.95, P = 0.04). Furthermore, the effect sizes of IL-1RN VNTR on sepsis risk increased with disease
severity (septic shock OR > severe sepsis OR > sepsis OR).
Conclusions: Our meta-analysis indicated that IL-1A-889, IL-1B + 3954 and IL-1RN VNTR might be associated with
sepsis susceptibility. However, further studies with larger sample sizes and from homogenous populations would be
necessary to validate these findings.
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Sepsis is a complex clinical syndrome that results from a
systemic inflammatory response to bacteria and/or bac-
terial products [1]. Though there have been many ad-
vances in the development of antibiotics and supportive
care, sepsis remains a serious and deadly problem with
high mortality rates worldwide [2]. Therefore, predictive
markers to identify high-risk patients are urgently needed
for early detection and preventive care of sepsis. Cytokines
play vital roles in the regulation of host immune response,
and altered expression of cytokines is proven to be involved
the development of sepsis [3]. Previous research suggests
that the variations in the genes encoding cytokines are also* Correspondence: hellojjx@126.com
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reproduction in any medium, provided the orinvolved in the inflammatory responses and are responsible
for inter-individual differences in susceptibility to sepsis
and in its severity [4]. Delineating the variations in cytokine
genes, and associated differences in response to sepsis
might contribute to the development of new genetically tai-
lored diagnostic and therapeutic interventions that may im-
prove outcome in sepsis patients.
Interleukin-1 (IL-1) family is a critical mediator of im-
mune response to sepsis with two agonists (IL-1α and
IL-1β) and one antagonist (IL-1 receptor antagonist: IL-
1ra) [5-7]. Excessive IL-1 production is directly linked to
the development of shock, multi-organ system failure,
and death in patients and animals with sepsis, systemic
inflammatory response syndrome, and septic shock [7].
Clinical trials with recombinant IL-1ra in the treatment
of sepsis showed the highest mortality rate in thoseLtd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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that overproduction of either pro-inflammatory mediators
(IL-1α and IL-1β) or anti-inflammatory cytokines (IL-1ra)
might lead to organ dysfunction and even death [8].
IL-1A, IL-1B and IL-1RN genes (encoding IL-1α, IL-1β,
and IL-1ra, respectively) are located next to each other
within the cluster of human major histocompatibility com-
plex in the q13-21 area of human chromosome 2 [9]. Five
SNPs in IL-1 genes have been most frequently studied in
relation to sepsis risk: one SNP at promoter position −889
in the IL-1A gene, two SNPs at promoter position −511
and −31 and one SNP in exon 5 at position +3954 of the
IL-1B gene and a variable number of tandem repeats
(VNTR) of 86-bp sequence in intron 2 of IL-1RN gene, 5
alleles of which have been reported (1 to 5) corresponding
to 4, 2, 5, 3 and 6 copies of 86-bp sequence, respectively.
Thus, the IL-1RN alleles were further divided into two cat-
egories: long genotype (L: including alleles 1, 3, 4, and 5)
and short genotype (2: allele 2 only). The genotypes were
classified as L/L, L/2, and 2/2 [10].
Recently, a number of studies regarding the associa-
tions between IL-1 polymorphisms and sepsis risk have
been published [11-27]. However, the results reported
from these studies are inconsistent and inconclusive. We
performed a meta-analysis to further investigate the as-
sociations between IL-1 polymorphisms and sepsis risk,
which may help us to better clarify the effect of these
polymorphisms on sepsis susceptibility.
Methods
Identification and eligibility of relevant study
Relevant articles were identified through a literature
search using the keywords “IL-1 or interleukin-1 or IL1”
and “sepsis or severe sepsis or septic shock” and “poly-
morphism or genetic variant or mutation” in Pubmed,
Embase, and Web of Knowledge databases until Jun 15,
2013. All searched articles were retrieved and their refer-
ences were checked for other relevant publications.
The inclusion criteria were: (a) studies evaluating the as-
sociation between IL-1 polymorphisms and sepsis risk, (b)
case–control study or cohort design, (c) sufficient data
(genotype distributions of cases and controls), and (d) stud-
ies written in English. We excluded reviews, comments and
articles from which the necessary data could not be ex-
tracted nor obtained after contacting the authors. In cases
of overlapping studies, only the study with the largest sam-
ple size was included.
To minimize the bias and improve the reliability, two re-
searchers reviewed these articles with the inclusion and
exclusion criteria independently and reached a consensus.
Data extraction
Data extraction was independently performed by two in-
vestigators and discrepancies were settled by reaching aconsensus. Information such as the first author’s name,
publication year, country and ethnicity of participants,
sepsis severity, genotyping method, genotype number or
allele frequencies for cases and controls was collected
from each study using a standardized data collection
protocol. For studies including subjects of different pop-
ulations, data were extracted separately.Qualitative assessment
Quality assessment was performed with the Newcastle-
Ottawa quality assessment scale (NOS) [28]. A ‘star sys-
tem’ has been used to judge data quality based on three
broad perspectives: the selection, comparability and out-
come of interest. Stars are added up to compare the
study quality in a quantitative fashion. The scores ranged
from 0 to 9 stars. Studies with scores of 7 stars or
greater were considered to be of high quality. Based on
these criteria, the content validity was evaluated by J-
WG and C-LY, and any disagreement was resolved via
discussions between and or with the other authors for
adjudication.Statistical analysis
The associations between IL-1 polymorphisms and sepsis
risk were estimated by calculating pooled ORs and 95%CI
under the dominant (BB +AB vs. AA), recessive (BB vs.
AB +AA), and allelic (B vs. A) genetic models respectively
(B represented minor allele, A represented major allele). A
random-effects model, using Mantel-Haenszel method,
was used to calculate pooled ORs. The significance of
pooled ORs was determined with Ζ tests (P < 0.05 was
considered statistically significant). Departure from Hardy-
Weinberg equilibrium (HWE) in controls was tested
via a Chi-square test at a significance level of P < 0.05.
Heterogeneity between studies was assessed using the
Cochrane Q test and the I2 statistic [29]. Multivariate
meta-regression was performed to explore potential sources
of heterogeneity among the following covariates: ethnicity
(divided into Asian, Caucasian and others), sepsis severity
(divided into sepsis, severe sepsis and septic shock), sources
of controls (divided into community- or hospital-based)
and sample size using REML method of random-effects
when the number of studies was more than or equal to 10
[30]. Subgroup analyses were carried out based on ethnicity,
severity of sepsis, and quality score. To assess the stability
of the pooled results, sensitivity analysis was performed by
sequentially excluding individual studies one by one. The
publication bias was examined by funnel plot [31] and
Egger’s test [32]. To adjust the values for multiple com-
parisons in subgroup analyses, we used the Benjamini-
Hochberg (BH) step-up correction method, which control
the false discovery rate (FDR) [33]. All statistical tests were
performed using Review Manager 5.2 (The Cochrane
Zhang et al. BMC Medical Genetics 2014, 15:8 Page 3 of 14
http://www.biomedcentral.com/1471-2350/15/8Collaboration, Oxford, UK) and STATA11.0 software
(StataCorp LP, College Station, Texas, USA).
Result
Characteristics of eligible studies
A total of 429 articles were identified update to Jun 15,
2013 (107 from PubMed, 144 from Embase, and 178
from Web of Knowledge). After scanning the abstracts
and checking the full-text articles, seventeen articles met
the inclusion criteria. Furthermore, two populations con-
taining Caucasian and Black subjects were included in
one article by Johnson et al. [13] which was therefore
considered as two independent studies (referred to as
Johnson-1 and Johnson-2) in the following data analysis.
Thus, 18 studies addressing five polymorphisms in IL-1
gene were included in our meta-analysis (Flow diagram
shown in Figure 1).
The characteristics of included studies are listed in
Table 1. Of these 18 studies, eight were conducted in
Caucasian, six in Asian, two in Hispanic, one in African-
American, and one in Jewish/Arabic populations. Except
for one study for IL-1B + 3594 and another for IL-1RN
VNTR, the genotype frequency distributions of others
were in agreement with HWE (Table 1). Quality scores
for individual studies ranged from 6 to 9, with 78% (14 of
18) of the studies being classified as high quality (score ≥ 7)
(Additional file 1: Table S1). The classical polymerase chain
reaction (PCR) and PCR-restriction fragment length poly-
morphism (PCR-RFLP) were the most commonly used
genotyping method in these studies.
Quantitative data synthesis
IL-1A-889 (rs1800587) polymorphism
Only two studies [15,17] with high quality containing 193
cases and 193 controls evaluated the association of the IL-
1A-889 polymorphism (rs1800587) with sepsis risk. In
overall comparison, a significant association was observed
for allelic effect (OR = 1.47, 95% CI = 1.01-2.13, P = 0.04).
There were no statistically significant associations between
this polymorphism and sepsis risk under dominant or re-
cessive models (Additional file 2: Figure S1, Table 2).
IL-1B-511 (rs16944) and −31 (rs1143627) polymorphisms
Seven studies [12-15,17,34] totaling 745 cases and 750
controls were identified in order to investigate the asso-
ciation between IL-1B-511 polymorphism (rs16944) and
sepsis risk. Overall, the results showed no associations
under any genetic model. Removal of the low score study
([34] with score = 6), did not alter these results. In addition,
there was no association in any subgroup analysis, either
based on ethnicity or sepsis severity under any genetic
model (Additional file 2: Figure S2, Table 2).
For the IL-1B-31 polymorphism (rs1143627), four studies
[14-16,22] with high quality totaling 405 cases and 824controls were identified. Similar to IL-1B-511 polymorph-
ism, there were no significant associations detected be-
tween rs1143627 and sepsis risk overall or in any subgroup
analysis for any genetic model (Additional file 2: Figure S3,
Table 2).IL-1B + 3594 (rs143634) polymorphism
Six studies [13,20,23,24,27] containing 680 cases and
998 controls were identified that evaluated the associ-
ation between the IL-1B + 3594 polymorphism (rs143634)
and sepsis risk. In the overall comparison, the IL-1B +
3594 polymorphism was significantly associated with
sepsis risk in the recessive effect (OR = 0.59, 95% CI =
0.36-0.97, P = 0.04, PFDR = 0.12) (Figure 2, Additional
file 2: Figure S4). In the subgroup analyses based on
ethnicity and sepsis subtype, the significant results persisted
in the Caucasian populations (OR = 0.57, 95% CI = 0.34-
0.95, P = 0.03, PFDR = 0.09) and in sepsis subgroup patients
(OR = 0.55, 95% CI = 0.31-0.97, P = 0.04, PFDR = 0.12). How-
ever, the negative results for Asians, severe sepsis, and
septic shock group patients might be not reliable be-
cause only one study was performed in each subgroup
(Table 2). After the exclusion of the study by Fang et al.
[27], whose genotypic distribution in controls deviated
from HWE (PHWE = 0.03), the results did not vary signifi-
cantly (OR = 0.55, 95% CI = 0.31-0.97, P = 0.04, PFDR = 0.12
for overall studies; OR = 0.51, 95% CI = 0.28-0.93, P = 0.03,
PFDR = 0.09 for Caucasian populations). Furthermore, the
results of stratified analysis based on quality score were not
statistically significant.IL-1RN VNTR polymorphism
For the IL-1RN VNTR polymorphism, ten studies [11,12,
17,19,21,24-27,34] comprised of 701 cases and 1227 con-
trols were identified. However, one study by Bessler et al.
[21] that deviated from HWE (PHWE = 0.002) was not
included into the final meta-analysis. The overall results
suggested there was statistically significant association
of this polymorphism with sepsis risk under allelic
model (OR = 1.40, 95% CI = 1.01-1.95, P = 0.04, PFDR =
0.12) (Figure 3, Additional 1: Additional file 2: Figure S5). A
similar trend was observed in Asian patients (OR = 1.69,
95% CI = 1.01-2.84) although the results were not statisti-
cally significant (P = 0.05, PFDR = 0.15). Further stratified
analyses based on sepsis severity showed that the effect
sizes of IL-1RN VNTR on sepsis risk increased with disease
severity (septic shock patients > severe sepsis patients > sep-
sis patients). These findings needed to be interpreted with
caution since only one or two studies were included under
the three genetic models. Furthermore, stratified analysis
based on quality score indicated that there was not sig-
nificant association in the high quality studies (Quality
score ≥7) (Table 2).
Figure 1 Flow of study identification, inclusion, and exclusion. *represents that certain studies will appear in more than one group when
they are divided by polymorphism.
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As shown in Table 2, obvious evidence (P < 0.1 and I2 >
50%) for heterogeneity between studies was found for IL-
1B-511 or IL-1RN VNTR under all three genetic models,
and for IL-1B-31 under dominant and allelic models. No
evidence for heterogeneity between studies was found for
IL-1A-889 or IL-1B + 3594 under any genetic model.To explore potential sources of between-study hetero-
geneity in our assessment of IL-1RN VNTR polymorphism
and sepsis susceptibility, meta-regression was conducted
for all three genetic models. The confounding factors
included ethnicity, sepsis severity, sources of controls,
and sample size. However, the result did not indicate
that any of these potential factors was a major source of
Table 1 Characteristics of studies included in the meta-analysis
Author/Year Country Ethnicity Sepsis
severity







A AB BB AA AB BB
IL1α-889C/T
Davis 2010 America Hispanic Sepsis Community TaqMan 7 28/52 16 3 24 24 4 0.55
Gu 2010 China Asian Sepsis Hospital (trauma) Probes 8 165/141 1 42 9 107 31 3 0.67
IL-1B-511G/A
Johnson-1 2012 America Caucasian Sepsis Hospital (noninfected) Mass-array 9 245/263 1 114 28 101 120 42 0.53
Johnson-2 2012 America African-American Sepsis Hospital (noninfected) Mass-array 9 93/88 36 29 26 43 19 0.88
Wan 2012 China Asian Sepsis Hospital (transplanted) PCR-RFLP 7 21/60 6 4 12 30 18 0.94
Shimada 2011 Japan Asian Sepsis Hospital (critical ill) Probes 7 123/101 60 30 35 46 20 0.49
Davis 2010 America Hispanic Sepsis Community TaqMan 7 28/53 6 5 19 29 5 0.20
Gu 2010 China Asian Sepsis Hospital (trauma) Probes 8 167/140 83 27 34 61 45 0.15
Watanabe 2005 Japan Asian Sepsis Hospital (SIRS) Probes 6 68/45 49a 20 25a 0.86
IL-1B-31C/T
Shimada 2011 Japan Asian Sepsis Hospital (critical ill) Probes 8 122/101 58 28 34 47 20 0.61
Emonts 2010 Netherlands Caucasian Sepsis Community SNaPshot 7 84/456 37 37 57 214 185 0.69
Gu 2010 China Asian Sepsis Hospital (trauma) Probes 8 163/144 106 28 66 60 18 0.45
Barber 2004 America Caucasian SS Hospital (burn) Pyro 8 36/123 13 12 21 54 48 0.39
IL-1B + 3594C/T
Johnson-1 2012 America Caucasian Sepsis Hospital (noninfected) Mass-array 9 245/263 1 89 8 158 88 17 0.32
Johnson-2 2012 America African-American Sepsis Hospital (noninfected) Mass-array 9 93/88 29 3 65 20 3 0.36
Zhang 2005 China Asian SSH Hospital (ASP) PCR-RFLP 6 33/76 6 0 68 8 0 0.63
Balding 2003 Ireland Caucasian Sepsis Community PCR-RFLP 6 183/389 1 65 5 240 125 24 0.16
Treszl 2003 Hungary Caucasian Sepsis Hospital (VLBW) PCR-RFLP 6 33/70 11 2 41 25 4 0.94
Fang 1999 Germany Caucasian SS Community PCR 7 93/112 31 7 68 33 11 0.03
IL-1RN VNTR L/2
Zapata-Tarres 2013 Mexico Hispanic SSH Hospital (ALL) PCR 8 22/35 11 5 23 11 1 0.82
Wan 2012 China Asian Sepsis Hospital (transplanted) PCR-RFLP 7 21/60 4 0 51 9 0 0.53
Davis 2010 America Hispanic Sepsis Community TaqMan 7 28/50 14 2 27 20 3 0.78
Garcia-Segarra 2007 Spain Caucasian SS and SSH Community PCR 7 114/80 52 3 30 41 9 0.37











































Table 1 Characteristics of studies included in the meta-analysis (Continued)
Bessler 2004 Israel Jews/Arabs Sepsis Community PCR 7 34/61 18 10 6 33 16 12 0.002
Balding 2003 Ireland Caucasian Sepsis Community PCR-RFLP 6 183/389 88 70 25 198 160 31 0.87
Arnalich 2002 Spain Caucasian SS Hospital (CAP) PCR 8 78/186 32 33 13 88 81 17 0.79
Ma 2002 China Asian Sepsis Community PCR 7 60/60 26 27 7 36 21 3 0.98
Fang 1999 Germany Caucasian SS Community PCR 7 93/261 37 43 13 152 92 17 0.54
SS: severe sepsis; SSH: septic shock; SIRS: systemic inflammatory response syndrome; ASP: acute severe pancreatitis; VLBW: very-low-birth-weight infants; ALL: acute lymphoblastic leukemia; CAP: community-acquired




















Table 2 Summary of meta-analysis results
Dominant model Recessive model Allelic model
n OR (95% CI) P-value Phet I
2 n OR (95% CI) P-value Phet I
2 n OR (95% CI) P-value Phet I
2
IL1A-889C/T
Total (sepsis) 2 1.49 (0.95-2.33) 0.08 0.65 0% 2 2.06 (0.75-5.67) 0.16 0.56 0% 2 1.47 (1.01-2.13) 0.04 0.98 0%
Ethnicity
Asian 1 1.41 (0.85-2.34) 0.19 1 2.65 (0.70-10.0) 0.15 1 1.47 (0.94-2.30) 0.09
Others 1 1.81 (0.69-4.74) 0.23 1 1.44 (0.30-6.94) 0.65 1 1.46 (0.74-2.87) 0.28
IL1B-511G/A
Total (sepsis) 7 0.81 (0.53-1.24) 0.33 <0.01 68% 6 0.89 (0.53-1.50) 0.66 <0.01 67% 6 0.82 (0.60-1.11) 0.20 <0.01 69%
Ethnicity
Asian 4 0.85 (0.39-1.87) 0.69 <0.01 81% 3 0.67 (0.29-1.55) 0.35 0.02 73% 3 0.74 (0.38-1.34) 0.29 <0.01 84%
Caucasian 1 0.86 (0.60-1.23) 0.40 1 0.68 (0.41-1.13) 0.14 1 0.84 (0.65-1.08) 0.18
Others 2 0.63 (0.24-1.66) 0.35 0.09 66% 2 1.73 (0.95-3.14) 0.07 0.76 0% 2 0.98 (0.58-1.65) 0.93 0.18 44%
Quality score
≥7 6 0.72 (0.48-1.9) 0.12 0.02 64% 6 0.89 (0.53-1.50) 0.66 <0.01 67% 6 0.82 (0.60-1.11) 0.20 <0.01 69%
<7 1 2.06 (0.94-4.55) 0.07
IL1B-31C/T
Total (high quality) 4 1.29 (0.54-3.06) 0.57 <0.01 86% 4 1.16 (0.86-1.56) 0.34 0.69 0% 4 1.18 (0.78-1.77) 0.43 <0.01 78%
Ethnicity
Asian 2 2.19 (0.70-6.90) 0.18 <0.01 89% 2 1.33 (0.84-2.09) 0.22 0.69 0% 2 1.53 (0.91-2.57) 0.11 0.04 77%
Caucasian 2 0.73 (0.33-1.61) 0.43 0.15 52% 2 1.04 (0.70-1.56) 0.85 0.40 0% 2 0.90 (0.57-1.43) 0.65 0.14 55%
Sepsis severity
Sepsis 3 1.75 (0.74-4.11) 0.20 <0.01 84% 3 1.24 (0.89-1.72) 0.20 0.85 0% 3 1.37 (0.93-2.00) 0.11 0.03 72%
Severe sepsis 1 0.47 (0.20-1.10) 0.08 1 0.78 (0.36-1.71) 0.54 1 0.68 (0.40-1.15) 0.15
Septic shock
IL1B + 3594C/T
Total 6 1.06 (0.86-1.31) 0.57 0.79 0% 5 0.59 (0.36-0.97) 0.04 0.81 0% 6 0.97 (0.81-1.15) 0.72 0.71 0%
Ethnicity
Asian 1 1.89 (0.60-5.96) 0.28 1 1.80 (0.60-5.41) 0.30
Caucasian 4 1.00 (0.80-1.25) 0.99 0.74 0% 4 0.57 (0.34-0.95) 0.03 0.74 0% 4 0.92 (0.76-1.11) 0.37 0.99 0%
Others 1 1.48 (0.78-2.81) 0.23 1 0.94 (0.19-4.81) 0.95 1 1.34 (0.77-2.33) 0.31
Sepsis severity



















Table 2 Summary of meta-analysis results (Continued)
Severe sepsis 1 1.07 (0.61-1.87) 0.82 1 0.75 (0.28-2.01) 0.56 1 0.98 (0.62-1.54) 0.93
Septic shock 1 1.89 (0.60-5.96) 0.28 1 1.80 (0.60-5.41) 0.30
Quality score
≥7 3 1.08 (0.82-1.42) 0.57 0.55 0% 3 0.63 (0.34-1.14) 0.13 0.71 0% 3 0.98 (0.78-1.23) 0.89 0.47 0%
<7 3 1.04 (0.75-1.43) 0.83 0.56 0% 3 0.53 (0.23-1.25) 0.15 0.37 0% 3 0.95 (0.72-1.24) 0.70 0.49 0%
IL1RN VNTR L/2
Total 9 1.39 (0.97-1.98) 0.07 0.01 59% 8 1.67 (0.93-3.02) 0.09 0.04 54% 8 1.40 (1.01-1.95) 0.04 <0.01 72%
Ethnicity
Asian 3 1.55 (0.89-2.68) 0.12 0.58 0% 1 2.51 (0.62-10.21) 0.20 2 1.69 (1.01-2.84) 0.05 0.64 0%
Caucasian 4 1.16 (0.72-1.88) 0.54 <0.01 75% 4 1.39 (0.66-2.92) 0.38 0.02 71% 4 1.17 (0.77-1.78) 0.45 <0.01 82%
Others 2 2.68 (0.84-8.50) 0.09 0.12 58% 2 3.17 (0.40-25.32) 0.28 0.15 52% 2 2.27 (0.78-6.58) 0.13 0.05 73%
Sepsis severity
Sepsis 5 1.26 (0.95-1.67) 0.11 0.69 0% 4 1.85 (1.12-3.04) 0.02 0.82 0% 4 1.31 (1.05-1.64) 0.02 0.70 0%
Severe sepsis 2 1.67 (1.03-2.71) 0.04 0.18 44% 2 2.16 (1.25-3.72) 0.01 0.77 0% 2 1.60 (1.18-2.17) <0.01 0.25 24%
Septic shock 1 5.11 (1.59-16.46) 0.01 1 10.00 (1.08-92.49) 0.04 1 4.00 (1.72-9.31) <0.01
Quality score
≥7 7 1.53 (0.95-2.47) 0.08 <0.01 67% 7 1.62 (0.72-3.65) 0.24 0.02 61% 7 1.46 (0.96-2.21) 0.08 <0.01 75%
<7 2 1.11 (0.79-1.55) 0.55 0.84 0% 1 1.83 (1.04-3.20) 0.03 1 1.22 (0.93-1.60) 0.14
Random effects model is used whether or not heterogeneity exists; others contain African-American, Hispanic, and Jews/Arabs; n: the number of studies involved. OR: odds ratio; CI: confidence interval; P-value: P value



















Figure 2 Forest plot of sepsis susceptibility associated with IL-1B + 3594 polymorphism under the recessive model (TT vs. CT + CC). The
squares and horizontal line represent the individual study-specific OR and 95% CI. Area of squares is proportional to the weight of the individual
study to the overall pooled OR. The diamond at the bottom of the graph represents the pooled OR and 95% CI. Events1: Number of individuals
with TT genotype. OR, odds ratio; CI, confidence interval.
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file 3: Table S2-S4). Indeed, the heterogeneity might be
attributable to other factors, which regrettably remain un-
defined due to insufficient data. For the other two poly-
morphisms (IL-1B-511 and −31), meta-regression was not
performed due to the small number of included studies.
Sensitivity analysis
We removed one study per time from the overall pooled
analysis to evaluate the influence of the removed data
set on the pooled ORs. The corresponding pooled ORs
under any genetic model were not materially altered for
IL-1A-889, IL-1B-511, and −31, respectively (Additional
file 4: Table S5-S7). However, for IL-1B + 3594, two stud-
ies (Johnson-1 et al. [13] and Balding et al. [24]) altered
the corresponding statistical P value of association under
the recessive model (Additional file 4: Table S8b). For IL-
1RN VNTR, one study (Garcia-Segarra et al. [19]) was iden-
tified as the main cause of heterogeneity. After exclusion ofFigure 3 Forest plot of sepsis susceptibility associated with IL-1RN VN
and horizontal line represent the individual study-specific OR and 95% CI. A
the overall pooled OR. The diamond at the bottom of the graph represent
ratio; CI, confidence interval.this study, the heterogeneity no longer existed, moreover,
positive association was increased under all three genetic
models (Additional file 4: Table S9).
Publication bias
Publication bias was examined by funnel plots and Egger’s
test under all genetic models. After combining all studies,
a little asymmetry was observed for IL-1RN VNTR poly-
morphism (Figures 4, 5 and 6), but Egger’s test did not
show evidence of publication bias (dominant: P = 0.519,
recessive: P = 0.724, allelic: P = 0.640). For IL-1A-889, IL-
1B-511, -31, and +3594 polymorphisms, publication bias
testing was not performed due to the small number of in-
cluded studies (n < 9).
Discussion
In this meta-analysis, two polymorphisms (IL-1B + 3594
and IL-1RN VNTR) were significantly associated with
sepsis susceptibility in overall comparison and subgroupTR polymorphism under the allelic model (2 vs. L). The squares
rea of squares is proportional to the weight of the individual study to
s the pooled OR and 95% CI. Events1: Number of the 2 allele. OR, odds
Figure 4 Funnel plot of sepsis susceptibility associated with IL-1RN VNTR under the dominant model (2/2 + L/2 vs. L/L). Each circle represents
an independent study; for each study the OR was plotted against the standard error of the log of the OR. Center dotted line represents the pooled OR
and sloping dotted lines represent the 95% CI of the pooled OR. OR, odds ratio; SE, standard error; CI, confidence interval.
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http://www.biomedcentral.com/1471-2350/15/8analyses based on sepsis severity, whereas IL-1A-889 poly-
morphism influenced sepsis risk only in overall compari-
son. In contrast, no association was observed between
either IL-1B-511 or −31 and sepsis risk in overall compari-
son or subgroup analyses.
IL-1B + 3594 polymorphism is a coding synonymous
variant located in exon 5 of IL-1B. The transition from
C to T does not change amino acid coding but may lead
to an inactivation of the original splicing donor site. The
alternative splicing results in a premature stop codon or
exon skipping and produces a truncated protein that isFigure 5 Funnel plot of sepsis susceptibility associated with IL-1RN VNT
an independent study; for each study the OR was plotted against the standar
and sloping dotted lines represent the 95% CI of the pooled OR. OR, odds ratlikely to be rapidly degraded or functionally inactive [35].
The IL1B + 3954 T allele has been reported to increase the
production of IL-1β protein in response to LPS-stimulation
[36]. The results of our meta-analysis revealed that individ-
uals with variant genotype (TT) were less susceptible to
sepsis than individuals with CC or CT genotypes in overall
comparison and Caucasian population, which was incon-
sistent with higher IL-1β levels associated with increased
risk of sepsis. Considering that sepsis is a multifactorial trait
and the impact of the inflammatory cytokine on sepsis
progress may be modulated by other environmental andR under the recessive model (2/2 vs. L/2 + L/L). Each circle represents
d error of the log of the OR. Center dotted line represents the pooled OR
io; SE, standard error; CI, confidence interval.
Figure 6 Funnel plot of sepsis susceptibility associated with IL-1RN VNTR under the allelic model (2 vs. L). Each circle represents an
independent study; for each study the OR was plotted against the standard error of the log of the OR. Center dotted line represents the pooled
OR and sloping dotted lines represent the 95% CI of the pooled OR. OR, odds ratio; SE, standard error; CI, confidence interval.
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http://www.biomedcentral.com/1471-2350/15/8genetic factors, more studies should be conducted to
clarify the role of IL-1B + 3594 polymorphism in the eti-
ology of sepsis.
For the IL-1RN VNTR polymorphism, functional ana-
lysis in vitro has shown that the IL-1RN-2 allele corre-
lated with high IL-1ra level and an even more elevated
IL-1β level. This resulted in the lowest IL-1ra/IL-1β ratio
and was associated with a strengthened and prolonged
inflammatory response [37,38]. In addition, Arnalich et al.
[26] found that IL-1RN-2 allele causes a decreased pro-
duction of serum IL-1Ra in patients with severe sepsis and
ethnically matched healthy controls compared with 1 al-
lele. These findings implied that the 86 bp VNTR poly-
morphism of the IL-1RN has potential roles in regulating
the immune response and contributed to the pathogenesis
of inflammatory diseases. Similarly, our meta-analysis in-
dicated a significant association with risk of sepsis in over-
all comparison and stratified analysis based on different
sepsis severity, which was not observed in ethnicity sub-
group analysis. This indicates that the discrepancies be-
tween the overall and ethnicity subgroup analyses may be
attributed to the diverse genetic backgrounds and envir-
onmental factors influencing sepsis risk in different ethnic
populations. Further studies with larger samples and from
homogeneous populations are warranted to further evalu-
ate the role of the IL-1RN VNTR polymorphism in sepsis
risk in different populations.
IL-1A-889 polymorphism, a C-to-T point mutation in
its 5’ regulatory region, affected over-expression of IL-1α
[35]. In the current meta-analysis, there was significant
association with sepsis susceptibility in overall compari-
son. However, only two studies were included into thismeta-analysis with small samples. Thus, this finding needed
to be confirmed with larger samples.
The −511 and −31 polymorphisms, which are located
at position 511 bp and 31 bp upstream of the transcrip-
tional start site, have been shown to influence the tran-
scriptional activity and expression of the IL-1B gene.
The presence of variant allele of IL-1B-511 markedly in-
creased endotoxin-induced production of IL-1β [36].
Moreover, IL1B-31C/T substitution located in the TATA
box motif has been found to markedly affect the binding
of several transcription factors and thereby affect the
transcriptional activity [39]. In addition, two bi-allelic
SNPs (−511, and −31) within the human IL-1B promoter
region have been reported to affect LPS-induced IL-1β
transcription in vitro and IL-1β plasma levels in healthy
adults [40]. Although IL-1β plays an important role in
sepsis and IL-1β is frequently over-expressed in sepsis,
our meta-analysis indicated no significant association be-
tween the IL-1B-511 and −31 polymorphisms and sepsis
risk, suggesting that IL-1β expression might influence
sepsis progression via mechanisms other than regulation
by the two promoter polymorphisms. Several other fac-
tors, such as IL-1RN and NLRP3 may also regulate IL-1β
expression [41,42]. Further studies are needed to test
these hypotheses.
Sepsis is a multifactorial trait and the impact of the in-
flammatory cytokine on sepsis progress may be modulated
by, age, gender and some other environmental factors
[43]. Interpretation of the pooled results has been ham-
pered by the fact that several different clinical conditions
such as sepsis, severe sepsis, or septic shock have been
analyzed together according to the published consensus
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also examined that whether the effect of polymorphisms
differed depending on the way in which sepsis was de-
scribed (sepsis, severe sepsis, or septic shock). Our re-
sults indicated the positive association was observed for
IL-1B + 3594C/T in sepsis group patients, for IL-1RN
VNTR polymorphism in sepsis, severe sepsis, and septic
shock group patients, respectively. These findings indi-
cated that the way in which sepsis was described af-
fected the association between IL-1 polymorphisms and
susceptibility to sepsis. However, what also needs to be
pointed out is that these significant associations were
derived from only one to two studies and thus the result
should be interpreted with caution because of the rela-
tively small sample size.
Heterogeneity is an important problem when interpret-
ing the results of our meta-analysis. In this study, signifi-
cant heterogeneity was found for the IL-1B-511, -31, and
IL-1RN VNTR polymorphisms. Meta-regression did not
seem to reveal the potential sources of heterogeneity with
the introduction of covariates containing ethnicity, sepsis
severity, sources of controls, sample size, which indicated
that the heterogeneity might be attributable to other
factors, which regrettably remain undefined due to in-
sufficient data. Moreover, we carried out sensitivity ana-
lysis. Removal of each study did not seem to alter the
relationships with sepsis risk and heterogeneity for IL-
1B-511 and −31, suggesting the reliability of these re-
sults. However, removing one study by Garcia-Segarra
et al. for IL-1RN VNTR obviously decreased the hetero-
geneity and increased positive association under all gen-
etic models, which indicated this study may be the main
cause of heterogeneity.
Another important problem is publication bias. Because
meta-analyses review quantitative data from numerous
studies, the publication bias effect of the literature incor-
porated in the study can bias the mea-analytic outcome.
For IL-1RN VNTR polymorphism, although the Egger’s
test did not show significant publication bias for sepsis
risk, we found the shape of the funnel plot was slightly
asymmetrical. Thus, the results should be interpreted cau-
tiously and more studies are still needed to confirm the
findings from this meta-analysis.
Some limitations of this meta-analysis should be pointed
out. First, the number and sample size of the included stud-
ies was limited, some unpublished reports, non-English ar-
ticles and studies without sufficient information were not
included in our meta-analysis, which might bias the pooled
results. Second, although the results in stratified analysis
were more meaningful, there were a small number of stud-
ies in each stratum, thus limiting the interpretation of these
analyses. Third, as none of the studies included in this
meta-analysis considered the effect of gene-gene/environ-
ment involved in the pathogenesis of sepsis, this issue couldnot be addressed. Fourth, the overall outcome was based
on unadjusted data, where as a more precise analysis strati-
fied by variables such as age, sex, type of infection etc. could
not be performed due to limitations of the data which also
restricted our ability to detect possible sources of het-
erogeneity. Fifth, stratified analyses based on the differ-
ent sources of controls were not performed due to small
number of studies in each subgroup; the inclusion of
studies with varied control populations might increase
the probability of typeIerror and bias the pooled results.
Finally, as we only focused on the associations between
IL-1 polymorphisms and sepsis susceptibility in the present
study, the significance was limited. To better illuminate the
role of IL-1 polymorphisms in outcome of sepsis, it would
also be important to perform meta-analyses on the asso-
ciations between polymorphisms and severity or sepsis-
related mortality in future studies.
Conclusions
To our knowledge, this is the first study that quantita-
tively synthesized the association between the IL-1
polymorphisms and sepsis. The results demonstrated
that the IL-1A-889C/T, IL-1B-3594C/T, and IL-1RN
VNTR polymorphisms had significant associations with
the risk of sepsis, although some results were limited
by the small number of studies. However, no significant
association existed between IL-1B-511, -31 and sepsis risk.
Further studies with large samples and homogeneous
population are needed to evaluate their associations
with sepsis risk.
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